<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">the </span>
   <span class="font17">for </span>
   <span class="font17">with </span>
   <span class="font16">are </span>
   <span class="font16">virus </span>
   <span class="font14">antiviral </span>
   <span class="font14">against </span>
   <span class="font13">[]. </span>
   <span class="font13">Res./j.antiviral... </span>
   <span class="font12">treatment </span>
   <span class="font12">viruses </span>
   <span class="font12">infections </span>
   <span class="font12">viral </span>
   <span class="font12">The </span>
   <span class="font12">antivirals </span>
   <span class="font12">compounds </span>
   <span class="font12">[], </span>
   <span class="font12">vitro </span>
   <span class="font12">fever </span>
   <span class="font11">activity </span>
   <span class="font11">has </span>
   <span class="font11">{background </span>
   <span class="font11">drug </span>
   <span class="font11">which </span>
   <span class="font11">been </span>
   <span class="font11">clinical </span>
   <span class="font11">infection </span>
   <span class="font11">but </span>
   <span class="font11">hemorrhagic </span>
   <span class="font11">influenza </span>
   <span class="font11">inhibitor </span>
   <span class="font11">biological </span>
   <span class="font11">not </span>
   <span class="font11">agents </span>
   <span class="font11">potential </span>
   <span class="font11">was </span>
   <span class="font11">broad-spectrum </span>
   <span class="font11">human </span>
   <span class="font11">margin </span>
   <span class="font11">that </span>
   <span class="font11">{border-style </span>
   <span class="font11">Ebola </span>
   <span class="font11">use </span>
   <span class="font11">effective </span>
   <span class="font11">have </span>
   <span class="font11">models </span>
   <span class="font11">px;} </span>
   <span class="font11">ribavirin </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">FDA </span>
   <span class="font11">animal </span>
   <span class="font11">research </span>
   <span class="font11">also </span>
   <span class="font11">approved </span>
   <span class="font11">efficacy </span>
   <span class="font11">favipiravir </span>
   <span class="font11">from </span>
   <span class="font11">number </span>
   <span class="font10">RNA </span>
   <span class="font10">encephalitis </span>
   <span class="font10">threat </span>
   <span class="font10">case </span>
   <span class="font10">developed </span>
   <span class="font10">drugs </span>
   <span class="font10">inhibits </span>
   <span class="font10">severe </span>
   <span class="font10">were </span>
   <span class="font10">cause </span>
   <span class="font10">causing </span>
   <span class="font10">other </span>
   <span class="font10">Zika </span>
   <span class="font10">cell </span>
   <span class="font10">development </span>
   <span class="font10">measles </span>
   <span class="font10">model </span>
   <span class="font10">used </span>
   <span class="font10">Chikungunya </span>
   <span class="font10">high </span>
   <span class="font10">including </span>
   <span class="font10">may </span>
   <span class="font10">polymerase </span>
   <span class="font10">shown </span>
   <span class="font10">This </span>
   <span class="font10">caused </span>
   <span class="font10">drugs. </span>
   <span class="font10">flaviviruses </span>
   <span class="font10">health </span>
   <span class="font10">novel </span>
   <span class="font10">only </span>
   <span class="font10">replication </span>
   <span class="font10">testing </span>
   <span class="font10">this </span>
   <span class="font10">treat </span>
   <span class="font10">yellow </span>
   <span class="font10">While </span>
   <span class="font10">available </span>
   <span class="font10">can </span>
   <span class="font10">cells </span>
   <span class="font10">currently </span>
   <span class="font10">design </span>
   <span class="font10">early </span>
   <span class="font10">infected </span>
   <span class="font10">inhibit </span>
   <span class="font10">into </span>
   <span class="font10">mouse </span>
   <span class="font10">resistance </span>
   <span class="font10">respiratory </span>
   <span class="font10">target </span>
   <span class="font10">their </span>
   <span class="font10">via </span>
   <span class="font10">virusAntivir </span>
   <span class="font10">well </span>
   <span class="font10">CHIKV </span>
   <span class="font10">Lassa </span>
   <span class="font10">active </span>
   <span class="font10">candidates </span>
   <span class="font10">cellular </span>
   <span class="font10">chikungunya </span>
   <span class="font10">compound </span>
   <span class="font10">disease </span>
   <span class="font10">effects </span>
   <span class="font10">entry </span>
   <span class="font10">enveloped </span>
   <span class="font10">evaluation </span>
   <span class="font10">fatality </span>
   <span class="font10">fevers </span>
   <span class="font10">inhibitors </span>
   <span class="font10">public </span>
   <span class="font10">px; </span>
   <span class="font10">requires </span>
   <span class="font10">shows </span>
   <span class="font10">small </span>
   <span class="font10">{font-family </span>
   <span class="font10">agents. </span>
   <span class="font10">all </span>
   <span class="font10">candidate </span>
   <span class="font10">containment. </span>
   <span class="font10">described </span>
   <span class="font10">font-size </span>
   <span class="font10">lethal </span>
   <span class="font10">many </span>
   <span class="font10">medical </span>
   <span class="font10">natural </span>
   <span class="font10">nucleoside </span>
   <span class="font10">potent </span>
   <span class="font10">significant </span>
   <span class="font10">small-molecule </span>
   <span class="font10">targeting </span>
   <span class="font10">targets </span>
   <span class="font10">two </span>
   <span class="font10">using </span>
   <span class="font10">vaccine </span>
   <span class="font10">viruses, </span>
   <span class="font10">Africa </span>
   <span class="font10">Crimean-Congo </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Venezuelan </span>
   <span class="font10">agent </span>
   <span class="font10">agents, </span>
   <span class="font10">alphaviruses </span>
   <span class="font10">approach </span>
   <span class="font10">between </span>
   <span class="font10">biodefense </span>
   <span class="font10">biothreat </span>
   <span class="font10">both </span>
   <span class="font10">considered </span>
   <span class="font10">countermeasures </span>
   <span class="font10">dengue </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">equine </span>
   <span class="font10">family </span>
   <span class="font10">fatal </span>
   <span class="font10">fever, </span>
   <span class="font10">first </span>
   <span class="font10">further </span>
   <span class="font10">hepatitis </span>
   <span class="font10">lead </span>
   <span class="font10">licensed </span>
   <span class="font10">list </span>
   <span class="font10">mainly </span>
   <span class="font10">mechanism </span>
   <span class="font10">members </span>
   <span class="font10">mice </span>
   <span class="font10">mortality </span>
   <span class="font10">most </span>
   <span class="font10">non-human </span>
   <span class="font10">outbreak </span>
   <span class="font10">outbreaks </span>
   <span class="font10">poxvirus </span>
   <span class="font10">primates </span>
   <span class="font10">recent </span>
   <span class="font10">recently </span>
   <span class="font10">review </span>
   <span class="font10">risk </span>
   <span class="font10">role </span>
   <span class="font10">silico </span>
   <span class="font10">smallpox </span>
   <span class="font10">sofosbuvir </span>
   <span class="font10">syndrome </span>
   <span class="font10">these </span>
   <span class="font10">toxicity </span>
   <span class="font10">under </span>
   <span class="font10">very </span>
   <span class="font10">virus-specific </span>
   <span class="font10">virusesAntivir </span>
   <span class="font10">vivo </span>
   <span class="font10">(Step </span>
   <span class="font10">(T-) </span>
   <span class="font10">(Table√Ç </span>
   <span class="font10">(e.g., </span>
   <span class="font10">AMed </span>
   <span class="font10">Agents </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Dengue </span>
   <span class="font10">Further </span>
   <span class="font10">Group </span>
   <span class="font10">However, </span>
   <span class="font10">Infect </span>
   <span class="font10">Res./S-()- </span>
   <span class="font10">West </span>
   <span class="font10">approval </span>
   <span class="font10">barrier </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">brincidofovir </span>
   <span class="font10">cases </span>
   <span class="font10">conditions </span>
   <span class="font10">development. </span>
   <span class="font10">does </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">endemic </span>
   <span class="font10">experimental </span>
   <span class="font10">filovirus </span>
   <span class="font10">filoviruses </span>
   <span class="font10">flavivirus </span>
   <span class="font10">focus </span>
   <span class="font10">give </span>
   <span class="font10">include </span>
   <span class="font10">interest </span>
   <span class="font10">interesting </span>
   <span class="font10">large </span>
   <span class="font10">new </span>
   <span class="font10">numbers </span>
   <span class="font10">outcomes </span>
   <span class="font10">paramyxoviruses </span>
   <span class="font10">patients </span>
   <span class="font10">promising </span>
   <span class="font10">pulmonary </span>
   <span class="font10">rates </span>
   <span class="font10">reported </span>
   <span class="font10">solid; </span>
   <span class="font10">ss-RNA </span>
   <span class="font10">such </span>
   <span class="font10">tested </span>
   <span class="font10">therapeutic </span>
   <span class="font10">therapy </span>
   <span class="font10">transmission </span>
   <span class="font10">transmitted </span>
   <span class="font10">type </span>
   <span class="font10">vaccines </span>
   <span class="font10">will </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">BSL- </span>
   <span class="font10">CCHFV </span>
   <span class="font10">Chem </span>
   <span class="font10">Clin </span>
   <span class="font10">FGI- </span>
   <span class="font10">Handling </span>
   <span class="font10">Human </span>
   <span class="font10">MBDC </span>
   <span class="font10">Nipah </span>
   <span class="font10">OPV </span>
   <span class="font10">Other </span>
   <span class="font10">VEEV </span>
   <span class="font10">Valley </span>
   <span class="font10">]), </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">adenosine </span>
   <span class="font10">analogue </span>
   <span class="font10">any </span>
   <span class="font10">being </span>
   <span class="font10">bold </span>
   <span class="font10">brain </span>
   <span class="font10">bunyaviruses </span>
   <span class="font10">canine </span>
   <span class="font10">central </span>
   <span class="font10">combination </span>
   <span class="font10">compared </span>
   <span class="font10">compassionate </span>
   <span class="font10">complex </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">deliberate </span>
   <span class="font10">diseases </span>
   <span class="font10">distemper </span>
   <span class="font10">effect </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">evaluated </span>
   <span class="font10">examples </span>
   <span class="font10">few </span>
   <span class="font10">filo-, </span>
   <span class="font10">found </span>
   <span class="font10">genome </span>
   <span class="font10">global </span>
   <span class="font10">hantavirus </span>
   <span class="font10">host </span>
   <span class="font10">hosts </span>
   <span class="font10">infections, </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">its </span>
   <span class="font10">known </span>
   <span class="font10">models. </span>
   <span class="font10">molecule </span>
   <span class="font10">mostly </span>
   <span class="font10">need </span>
   <span class="font10">one </span>
   <span class="font10">options </span>
   <span class="font10">order </span>
   <span class="font10">overview </span>
   <span class="font10">pathogenic </span>
   <span class="font10">phase </span>
   <span class="font10">point </span>
   <span class="font10">potentially </span>
   <span class="font10">protease </span>
   <span class="font10">protein </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">rate </span>
   <span class="font10">reduces </span>
   <span class="font10">reduction </span>
   <span class="font10">regulatory </span>
   <span class="font10">relevance </span>
   <span class="font10">remdesivir </span>
   <span class="font10">rodent </span>
   <span class="font10">secondary </span>
   <span class="font10">select </span>
   <span class="font10">session </span>
   <span class="font10">show </span>
   <span class="font10">similar </span>
   <span class="font10">since </span>
   <span class="font10">some </span>
   <span class="font10">specific </span>
   <span class="font10">strains </span>
   <span class="font10">studies </span>
   <span class="font10">susceptibility </span>
   <span class="font10">then </span>
   <span class="font10">they </span>
   <span class="font10">treatments </span>
   <span class="font10">trial </span>
   <span class="font10">vaccinia </span>
   <span class="font10">virus, </span>
   <span class="font10">when </span>
   <span class="font10">while </span>
   <span class="font10">zoonotic </span>
  </p>
 </body>
</html>
